Sökning: "cancer school"
Visar resultat 1 - 5 av 38 avhandlingar innehållade orden cancer school.
1. Childhood overweight and pubertal timing as predictors of adult cancer in men
Sammanfattning : Background and Aim Obesity is one of the leading causes of cancer globally. The importance of overweight in childhood for adult cancer risk, independent of overweight status in young adulthood is still unknown. Furthermore, how male pubertal timing influences the risk of prostate cancer has not been established. LÄS MER
2. Childhood cancer and school
Sammanfattning : The school situation is one area identified as being affected during and after treatment for childhood cancer and only studied to a limited extent. A contributing factor to that school absence is not always recommended is uncertainty about whether it increases the risk of infection. LÄS MER
3. Exploring vitamin D and steroid hormone receptors – from healthy elderly to prostate cancer cells
Sammanfattning : The genetic background together with environmental factors and lifestyle are key contributors to the health of an individual. Genetic background is inherited and irreversible unless mutations occur. However, lifestyle habits (i.e. LÄS MER
4. Radiation-Induced Xerostomia in Chinese Patients with Head and Neck Cancer – An Explorative and Interventional study
Sammanfattning : Background: Radiation-induced xerostomia is a common oral complication of patients with head and neck cancer (HNC) undergoing radiotherapy (RT). This can lead to a series of functional oral disorders, particularly dental caries, and ultimately negatively affect their oral health and health-related quality of life (HRQoL). LÄS MER
5. Repurposing digitoxin in the treatment of pancreatic ductal adenocarcinoma : genotypic and phenotypic features as biomarkers for digitoxin sensitivity in vitro
Sammanfattning : The incidence of pancreatic ductal adenocarcinoma (PDAC) is increasing worldwide. The dismal prognosis and lack of effective treatments urges for increased research efforts in developing new treatment regimens. Since the development of new cancer treatments are expensive and time consuming, repurposing drugs is preferable when possible. LÄS MER